Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for animal species.

The company was founded on April 28, 1994 and is headquartered in Paris, France.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals36,62882.1%32,88886.3% -10.21%
Vaccines5,25111.8%5,23513.7% -0.31%
Animal Health2,7436.1%---
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD612015Chief Executive Officer & Director
Serge Weinberg662009Chairman
Jérôme Contamine602009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD662011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Executive Vice President-Medical Affairs
Robert Castaigne, PhD712000Independent Director
Claudie Haigneré MD, PhD602008Independent Director
Carole Piwnica592010Independent Director
Suet-Fern Lee592011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,287,105,713 1,156,997,968 89.9% 100,000 0.0% 89.9%
Shareholders
NameEquities%
Dodge & Cox 68,536,387 2.65%
Barrow, Hanley, Mewhinney & Strauss LLC 29,377,146 1.14%
Franklin Advisers, Inc. 20,688,292 0.80%
Fisher Asset Management LLC 12,492,035 0.48%
Hotchkis & Wiley Capital Management LLC 11,338,645 0.44%
Boston Partners Global Investors, Inc. 8,653,700 0.33%
Invesco Advisers, Inc. 7,858,979 0.30%
Federated Investment Management Co. 4,833,898 0.19%
Fidelity Management & Research Co. 4,643,185 0.18%
Managed Account Advisors LLC 4,232,000 0.16%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,505,69422.7%8,445,360,797 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%841,658,677 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%410,162,754 USD
Sanofi (SAN) 3,956,7080.31%318,520,296 USD
Zentiva SA (ROSCD) 312,341,64974.9%147,693,872 USD
JHL Biotech Inc (6540) 28,415,11114.9%64,297,997 USD
Myokardia Inc (MYOK) 3,668,89911.7%41,091,669 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%29,537,057 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.55%6,064,535 USD
Proteome Sciences plc (PRM) 0
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI SA5.12%109 848
JOHNSON & JOHNSON5.63%333 891
ROCHE HOLDING LTD.5.98%210 192
PFIZER INC.4.86%207 902
NOVARTIS AG4.72%202 648
MERCK & CO., INC.11.86%182 412
SANOFI4.38%109 848
GLAXOSMITHKLINE PLC4.96%100 321
BRISTOL-MYERS SQUIBB C..-4.57%94 408
ALLERGAN PLC17.63%92 033
ELI LILLY AND CO12.24%91 484
BAYER AG5.16%90 959
ABBOTT LABORATORIES18.20%78 935
ASTRAZENECA PLC3.55%73 199
NOVO NORDISK A/S-3.02%71 595
SHIRE PLC3.42%54 627
TAKEDA PHARMACEUTICAL ..10.63%37 688
TEVA PHARMACEUTICAL IN..-3.98%36 240
ASTELLAS PHARMA INC-5.84%29 394
MYLAN NV10.96%22 560
CHUGAI PHARMACEUTICAL ..11.62%18 684
Sector Pharmaceuticals - NEC
Sanofi SA : Connections
Financières SASA
Académie des Technologies
World Justice Project
Piasa SA
Fondation C.Génial
Madrigall SA
Pharmaceutical Research & Manufacturers of America
The Children's Aid Society, Inc.
Council on Foreign Relations, Inc.
Piasa Holding SAS
Sanofi-Aventis Europe SAS
Fondation pour l’Université de Lyon
Sanofi-Aventis Participations SA
Financière Climater SAS
New York State Bar Association
Maremma SASU
Stamford Law Corp.
Sanofi-Aventis U.S. LLC
Rickmers Trust Management Pte Ltd.
Financière Piasa SAS
AXA Group Solutions
Sanofi Pasteur Holding SA
International Bar Association
Sanofi Pasteur Holding Ltd.
Omnium Insurance & Reinsurance Co. Ltd.
Fondation Lacoste
Academie de l'air et de l'espace
L'Oréal Corporate Foundation
Naxos UK Ltd.
Academie des Sports
Research!America
Académie des Sciences et Technologies
King Abdullah University of Science & Technology
i2O Water Ltd.
Warp Drive Bio LLC
Elevance Renewable Sciences, Inc.
Select Music & Video Distribution Ltd.
Académie Nationale de Médecine
National Academy of Engineering
Big Red, Inc.
Institute of Medicine
NAXOS Capital Managers SARL
The Johns Hopkins University
Morgan Lewis Stamford LLC
MedImmune LLC
Weinberg Capital Partners SAS
Nanyang Technological University
International Federation of Pharmaceutical Manufacturers A
Stamford Corporate Services Pte Ltd.
National Committee on United States-China Relations, Inc.
AXA Asia SAS
Total Gestion Filiales
Singapore Bar
Total Upstream UK Ltd.
Singapore Academy of Law
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2017 People , Fundamentals and Ownership